Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock
SAN DIEGO, Aug. 14, 2024 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCsâ¢), today announced the pricing of its upsized underwritten public offering…
Double Good Secures Spot on Inc. 5000’s Fastest-Growing Companies List for 17th time
Impressive Growth and Social Initiatives Elevate Brand to Esteemed Recognition CHICAGO, Aug. 14, 2024 /PRNewswire/ — Double Good, a popcorn-based fundraising company that is dedicated to raising joy for America’s youth, was honored by Inc. Magazine today on its annual Inc. 5000 list. The…
PDD INVESTOR NOTICE: PDD Holdings Inc. f/k/a Pinduoduo Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO, Aug. 14, 2024 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of PDD Holdings Inc. f/k/a Pinduoduo Inc. (NASDAQ: PDD) publicly traded securities between April 30, 2021 and June 25, 2024, both dates inclusive (the “Class…
MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, Aug. 14, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Moderna, Inc. (“Moderna” or “the Company”) (NASDAQ: MRNA) and certain of its officers….
NNE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that NANO Nuclear Energy Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, Aug. 14, 2024 /PRNewswire/ — Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against NANO Nuclear Energy Inc. (“NNE” or “the Company”) (NASDAQ: NNE) and certain of its…
Seefried Industrial Properties and MDH Partners Secure 5-Acre Site in Gilbert, Arizona; Plans Call for Development of 59k SF Industrial Facility
GILBERT, Ariz., Aug. 14, 2024 /PRNewswire/ — Seefried Industrial Properties, with development partner MDH Partners, has acquired a 5.1-acre site in Gilbert, Arizona, with plans to develop Fiesta Tech Center, a state-of-the-art industrial facility spanning 59,723 square feet. Construction…
Liberty All-Star® Equity Fund July 2024 Monthly Update
BOSTON, Aug. 14, 2024 /PRNewswire/ — Below is the July 2024 Monthly Update for the Liberty All-Star Equity Fund (NYSE: USA). Liberty All-Star Equity Fund Ticker: USA Monthly Update, July 2024 Investment Approach: Fund Style: Large-Cap Core Fund Strategy: Combines three value-style and…
Liberty All-Star® Growth Fund, Inc. July 2024 Monthly Update
BOSTON, Aug. 14, 2024 /PRNewswire/ — Below is the July 2024 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG). Liberty All-Star Growth Fund, Inc. Ticker: ASG Monthly Update, July 2024 Investment Approach: Fund Style: All-Cap Growth Fund Strategy: Combines three growth…
Adventist HealthCare Earns Top Workplaces Recognition
Hospital System Stands Alone in D.C. Region with Its Second Consecutive Rankings GAITHERSBURG, Md., Aug. 14, 2024 /PRNewswire/ — Adventist HealthCare has again been honored as a great place to work, earning a spot on The Washington Post’s list of Top Workplaces 2024 in the Washington,…
Ivonescimab (PD-1/VEGF) Received Priority Review from China’s NMPA for First-Line Treatment of PD-L1 Positive NSCLC
The Second Indication of Ivonescimab in NSCLC 2L+ EGFRm NSCLC Already Approved in May 2024 HONG KONG, Aug. 14, 2024 /PRNewswire/ — Akeso, Inc. (HKEX: 9926.HK) (“Akeso,”) today announced that the National Center for Drug Evaluation of the State Drug Administration of the People’s Republic…